Stock BFRI BIOFRONTERA INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Biofrontera Inc.

Equities

BFRI

US09077D2099

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1.69 USD +1.81% Intraday chart for Biofrontera Inc. +1.20% -38.99%
Mar. 18 Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024
Mar. 15 Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024
Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Biofrontera Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Biofrontera Files Prospectus for Potential Secondary Stock Offerings
MT
Medicus Pharma Names COO
MT
Biofrontera Inc. announced that it has received $8 million in funding
CI
BIOFRONTERA AG ANNOUNCES REVISED STRATEGY
AQ
BIOFRONTERA AG, BIOFRONTERA TRANSFERS CLINICAL RESEARCH TO THE U.S.
AQ
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera Ag
CI
Biofrontera Inc. announced that it expects to receive $8 million in funding
CI
Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use
CI
Certain Warrants of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.
CI
Certain Common Stock of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.
CI
Certain Stock options of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.
CI
Biofrontera Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Biofrontera Inc. Terminates MidCap Business Credit Loan Agreement
CI
Transcript : Biofrontera Inc., Q3 2023 Earnings Call, Nov 10, 2023
Biofrontera Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Biofrontera Inc. Reaffirms Revenue Guidance for the Full Year 2023
CI
Earnings Flash (BFRI) BIOFRONTERA Reports Q3 Revenue $8.9M, vs. Street Est of $8.4M
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BFRI Stock
  4. News Biofrontera Inc.